Court Filing
EXHIBIT S-6 Amended Supplemental Expert Disclosure: Anne Nord The State has previously disclosed Anne Nord, Forensic Scientist and Laboratory Manager, as an expert witness in the field of controlled substances and toxicology. The State hereby incorporates its previous responses and attachments filed on December 18, 2024, and is hereby supplementing those responses as follows. Nord may testify to the laboratory process and procedure for receiving, storing, handling and returning evidence and what was done in this case with regards to lab item # 71. The analyst may testify to the laboratory method for testing controlled substances, which may include identification of drugs detected in the sample and sample weighing. The analyst may testify to the results of testing in this case and the process for approving and reporting results. Nord may testify regarding her involvement in this case in which Nord tested lab item # 71 (ziplock bag with trace of blue powder). Nord's conclusion was that the item was amphetamine (CII). Nord will explain how she came to this conclusion and what method (s) she used to test item # 71. Nord tested Item # 71 using the Idaho State Police Controlled Substance Analytical Method revision 13, specifically AM 1, AM 3, and AM 6. A copy of that method is available for online at: https://isp.idaho.gov/wpcontent/uploads/Forensics/archivedAMs/since/Controlled%20Subs tances / Controlled-Substances-Analytical-Methods-Rev13.pdf. Item 71 was analyzed by preparing two separate samples by diluting the blue powder in methanol and running each of those on a gas chromatograph mass spectrometer EXHIBIT S-6 STATE'S EXHIBIT exhibitsticker.com Amended Supplemental Expert Disclosure: Anne Nord (Sealed) S-6 1 CR01-24-31665 (GCMS). GCMS consists of two analytical techniques run in tandem, the gas chromatograph is used to separate compounds and provides selectivity based on physical and chemical characterizations. The mass spectrometer provides selectivity based on the compound's chemical structure. The results from those runs were compared to a known standard of amphetamine that was run under the same conditions. Nord will testify that from the comparison of the extracts to the known standard she concluded that the sample contained amphetamine. Due to the limited sample amount, more than half of the sample was consumed in analysis. Due to this, the extracts were packaged and returned in the evidence envelope with the original item. EXHIBIT S-6 Amended Supplemental Expert Disclosure: Anne Nord (Sealed) 2